Evidence of frequent dosing errors in paediatrics and intervention to reduce such prescribing errors

R Bolt1, J M Yates, J Mahon

  • 1Department of Oral Surgery, School of Clinical Dentistry, University of Sheffield, Sheffield, UK.

Insights

Paediatric drug prescribing errors are common, particularly with weight-adjusted doses, leading to potential under-dosing and reduced medication efficacy. Simple interventions can improve accuracy in prescription chart completion and dosing calculations.

Area of Science:

  • Medical Research
  • Paediatric Pharmacology
  • Surgical Patient Care

Background:

  • Drug prescribing is critical in inpatient care, with errors having severe consequences.
  • Paediatric prescribing is especially vulnerable due to weight-adjusted dosing.
  • Previous adult studies show high error rates; paediatric data and weight-adjusted dose accuracy are lacking.

Purpose of the Study:

  • To quantify errors in paediatric drug prescribing for oral and maxillofacial surgery patients.
  • To explore practical methods for reducing prescribing errors in this population.
  • To assess the accuracy of weight-adjusted dosing in paediatric inpatients.

Main Methods:

  • Retrospective evaluation of inpatient drug charts in a children's hospital.
  • Assessment of prescribing practices against established hospital standards.
  • Analysis of weight-adjusted dose variability to set auditing targets.

Main Results:

  • Prescriptions were written by maxillofacial and anaesthetic teams with similar error rates.
  • 13% of drug charts had errors in frequency prescribing.
  • Weight-adjusted doses showed a median under-dosage of -5.4% (IQR -12% to -0.6%).

Conclusions:

  • Prescription chart completion errors and weight-adjusted dose inaccuracies are frequent in paediatric patients.
  • Under-prescribing of weight-adjusted doses may reduce drug efficacy, e.g., analgesia.
  • Specialty-specific interventions can enhance the accuracy of drug chart completion and weight-adjusted dosing.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410